Literature DB >> 1708309

Characterization of a T suppressor cell line that downgrades experimental allergic encephalomyelitis in mice.

W Ofosu-Appiah1, F Mokhtarian.   

Abstract

A T-suppressor (Ts) cell line of CD8 phenotype was isolated from spleens of SJL/J mice that had recovered from experimental allergic encephalomyelitis (EAE) induced by injection of MBP-activated T cells. The Ts cell line inhibited the proliferation of MBP-sensitized T cells in vitro. Addition of recombinant IL-2 enhanced the Ts-mediated suppression. Adoptively transferred Ts line was able to downgrade EAE in mice subsequently challenged with MBP-activated T cells. The mechanism of suppression appeared to involve neither direct cytolysis of the effector T cells nor the production of a soluble suppressor factor. The findings suggest an in vivo role for suppressor T cells in the regulation of EAE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708309     DOI: 10.1016/0008-8749(91)90261-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Antiviral CD8⁺ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice.

Authors:  Jane E Libbey; Matthew F Cusick; Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neurovirol       Date:  2012-01-27       Impact factor: 2.643

2.  Characteristics of initial and reinduced experimental autoimmune encephalomyelitis.

Authors:  J W Lindsey
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.

Authors:  Terrence F Meehan; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

4.  Generation and characterization of a continuous line of CD8+ suppressively regulatory T lymphocytes which down-regulates experimental autoimmune orchitis (EAO) in mice.

Authors:  A Mukasa; C Hiramine; K Hojo
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.